214 related articles for article (PubMed ID: 14736838)
41. Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.
Johnson GR; Zhuang H; Khan J; Chiang SB; Alavi A
Clin Nucl Med; 2003 Oct; 28(10):815-20. PubMed ID: 14508272
[TBL] [Abstract][Full Text] [Related]
42. Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction.
Even-Sapir E; Yuzefovich B; Miller E; Bouhnik JP; Zak O; Lerman H; Lievshitz G; Levin C
J Nucl Med Technol; 2004 Dec; 32(4):190-7. PubMed ID: 15576340
[TBL] [Abstract][Full Text] [Related]
43. Staging and follow-up of gastrointestinal tumors with PET/CT.
Rosenbaum SJ; Stergar H; Antoch G; Veit P; Bockisch A; Kühl H
Abdom Imaging; 2006; 31(1):25-35. PubMed ID: 16333707
[TBL] [Abstract][Full Text] [Related]
44. Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?
Kang S; Ahn BC; Hong CM; Song BI; Lee HJ; Jeong SY; Lee SW; Lee J; Lee SJ
Nuklearmedizin; 2011; 50(3):116-21. PubMed ID: 21246162
[TBL] [Abstract][Full Text] [Related]
45. Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
Reinbacher KE; Pau M; Wallner J; Zemann W; Klein A; Gstettner C; Aigner RM; Feichtinger M
J Craniomaxillofac Surg; 2014 Oct; 42(7):1184-9. PubMed ID: 24726395
[TBL] [Abstract][Full Text] [Related]
46. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.
Picchio M; Sironi S; Messa C; Mangili G; Landoni C; Gianolli L; Zangheri B; Viganò R; Aletti G; De Marzi P; De Cobelli F; Del Maschio A; Ferrari A; Fazio F
Q J Nucl Med; 2003 Jun; 47(2):77-84. PubMed ID: 12865867
[TBL] [Abstract][Full Text] [Related]
47. Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma.
Buchbender C; Heusner TA; Lauenstein TC; Bockisch A; Antoch G
J Nucl Med; 2012 Aug; 53(8):1244-52. PubMed ID: 22782313
[TBL] [Abstract][Full Text] [Related]
48. Clinical utility of PET/CT in lymphoma.
Cronin CG; Swords R; Truong MT; Viswanathan C; Rohren E; Giles FJ; O'Dwyer M; Bruzzi JF
AJR Am J Roentgenol; 2010 Jan; 194(1):W91-W103. PubMed ID: 20028897
[TBL] [Abstract][Full Text] [Related]
49. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
[TBL] [Abstract][Full Text] [Related]
50. Recurrent colon cancer involving the urinary bladder identified with F-18 FDG PET/CT after forced diuresis.
Chen CJ; Chao TB; Shih DF
Clin Nucl Med; 2010 Apr; 35(4):258-9. PubMed ID: 20305415
[No Abstract] [Full Text] [Related]
51. The clinical role of CT/PET in oncology: an update.
Francis IR; Brown RK; Avram AM
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S68-75. PubMed ID: 16361139
[TBL] [Abstract][Full Text] [Related]
52. Positron emission and computed X-ray tomography: a coming together.
Costa DC; Visvikis D; Crosdale I; Pigden I; Townsend C; Bomanji J; Prvulovich E; Lonn A; Ell PJ
Nucl Med Commun; 2003 Apr; 24(4):351-8. PubMed ID: 12673162
[TBL] [Abstract][Full Text] [Related]
53. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.
Israel O; Kuten A
J Nucl Med; 2007 Jan; 48 Suppl 1():28S-35S. PubMed ID: 17204718
[TBL] [Abstract][Full Text] [Related]
54. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M
Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408
[TBL] [Abstract][Full Text] [Related]
55. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P
Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652
[TBL] [Abstract][Full Text] [Related]
56. Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
Hahn S; Bauer S; Heusner TA; Ebeling P; Hamami ME; Stahl A; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Dec; 80(3):670-4. PubMed ID: 20970938
[TBL] [Abstract][Full Text] [Related]
57. The role of FDG-PET imaging in the management of lymphoma.
Kostakoglu L; Leonard JP; Coleman M; Goldsmith SJ
Clin Adv Hematol Oncol; 2004 Feb; 2(2):115-21. PubMed ID: 16163171
[TBL] [Abstract][Full Text] [Related]
58. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT.
Wahl RL
J Nucl Med; 2004 Jan; 45 Suppl 1():82S-95S. PubMed ID: 14736839
[TBL] [Abstract][Full Text] [Related]
59. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience.
Tatsumi M; Cohade C; Nakamoto Y; Fishman EK; Wahl RL
Radiology; 2005 Dec; 237(3):1038-45. PubMed ID: 16304117
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer.
Yu HM; Liu YF; Hou M; Liu J; Li XN; Yu JM
Eur J Radiol; 2009 Oct; 72(1):104-13. PubMed ID: 18640802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
